A Clinical Trial Evaluating TG4050 in Head and Neck Cancer

NCT04183166 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Squamous Cell Carcinoma of Head and Neck

Interventions

DRUG: TG4050

Sponsor

Transgene